Golden Finance reports that MEI Pharma announced the acquisition of 929,548 Litecoins (LTC) at an average purchase price of $107.58, with a total value of approximately $110 million. The company becomes the first publicly listed company in the United States to use Litecoin as a primary reserve asset.
In addition, MEI Pharma has partnered with Litecoin founder Charlie Lee and GSR to launch a $100 million institutional treasury strategy.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
MEI Pharma announced the acquisition of 929,548 LTC, with a total value of approximately 110 million USD.
Golden Finance reports that MEI Pharma announced the acquisition of 929,548 Litecoins (LTC) at an average purchase price of $107.58, with a total value of approximately $110 million. The company becomes the first publicly listed company in the United States to use Litecoin as a primary reserve asset. In addition, MEI Pharma has partnered with Litecoin founder Charlie Lee and GSR to launch a $100 million institutional treasury strategy.